UPDATE 3-U.S and European regulators reviewing safety of heartburn drugs like Zantac
September 13, 2019 at 16:38 PM EDT
U.S. and European drug regulators said on Friday they are reviewing the safety of the widely taken heartburn drug ranitidine, commonly known by the brand name Zantac, after they found traces of a probable cancer-causing impurity in some versions of the medicine.